Now, the Lundquist Institute (TLI) and Vitalex Biosciences announce that they will move forward in the development of the second-generation fungal vaccine candidate known as VXV‑01—up to and including ...

The hydrogel preservation technology maintains cell viability for days at room temperature, removing cold-chain constraints.

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

A new method uses the auxin-inducible degron (AID) system to tune protein levels with precision in living C. elegans.

Investigations suggest V2P may be efficiently applied for the automated identification of causal variants in simulated and actual patient sequencing data across phenotypes.

Results open the door to therapies based on chronobiology, the branch of biology that studies how living organisms structure their physiological processes in time.

Pairing a drug that targets the PRDM9 gene with a cholesterol-lowering agent shrank brain tumors and improved survival in mice.

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

Cosmo Pharmaceuticals attracted welcome attention from investors and other market watchers after coming out with topline ...

In future, a more detailed understanding of the lung microbiome in pneumonia may enable improved diagnostics, prognosis, and therapeutics.

Their data suggests that tweaking the expression of FDX2 could make up for the loss of frataxin, the protein tied to FA's development.